CAN MY DRUG SCREEN BE WRONG?

Size: px
Start display at page:

Download "CAN MY DRUG SCREEN BE WRONG?"

Transcription

1 CAN MY DRUG SCREEN BE WRONG? Drug screens performed for compliance monitoring or as an initial step before prescribing opioids can have several sources of errors. One of the most frequent sources of error is physician lack of knowledge about false positives and false negatives for the specific drug screen they use. Some manufacturers will include these in documentation about the drug screens while others omit this information, but in either case the physician usually has not studied the data provided to determine the accuracy of the drug screen. As federal guidelines continue to target physicians who prescribe high dose opioids and states are targeting physicians prescribing opioids to a large number of patients, doctors that may have never tested patients with drug screens or confirmatory tests are now doing so. Many do not have the experience necessary to interpret the results properly. Drug screens, if the results are aberrant, should always be checked with a LC/MS or GC/MS method that is called a confirmation test. The confirmation tests are virtually 100% accurate in the drugs and metabolites in the body, but the physician may not be aware certain drugs may be metabolized into other drugs that would trigger both a urine drug screen as being positive and the confirmation test as being positive. TYPES OF SCREENING TESTS USED: 1. Urine immunoassay enzyme based testing. The cloned enzyme donor immunoassay, enzyme-multiplied immunoassay technique (EMIT), fluorescence polarization immunoassay (FPIA), immunoturbidimetric assay, and radioimmunoassay (RIA) are different methods to detect drugs in urine. However, the simple dipstick method uses one of the first two techniques. Some doctors have more advanced techniques (FPIA or immuno-turbidimetric) machines and charge significant amounts for these tests. They are more accurate than the dipstick methods, but are much less accurate than the confirmatory testing LC/MS or GC/MS. The immunoassay tests cannot be used as definitive proof of

2 substance abuse by the patient: if the patient states the test results are incorrect, then the sample must be sent for confirmation. However, if the patient confesses to have used some substance that would create a positive in the test for drugs not prescribed or in cases where an expected drug does not show up and the patient states they have not taken the medication in x number of days, then it may not be necessary for a confirmation test. 2. LC/MS or GC/MS. These confirmatory tests are performed outside of the office in a reference lab. Their findings are essentially 100% correct with no false positives or false negatives on testing. However, there may be unrecognized metabolites that would be expected to show a positive for a specific drug if the physician knew these drugs were being taken or knew enough about metabolism to make this connection. Frequently physicians lack this knowledge, causing them to erroneously accuse patients of engaging in substance abuse. LC stands for liquid chromatography. This technique uses a liquid flowing through a column of absorbent to separate out the different components of the urine, saliva, or blood. The sample then passes through a MS or mass spectrometer, that identifies each drug by hitting the drug

3 with a beam of electrons, causing the drug to both fragment and become positively charged. The drug passes through a vacuum with magnets in a quadripole configuration, causing the positively charged drug to bend in its course. As it strikes the collector at a certain point, the pattern of the positively charged parent and fragments are collected and displayed with a computer model used to identify the drug from its relative mass to charge ratios. The GC stands for gas chromatography- instead of the urine sample being dissolved in a liquid, intsead it is injected into a gas passing through a column under low pressure to separate out the components, then pass through the mass spectrometer. There are extremely few false positives or negatives, and unlike immunoassay that a low sensitivity, the LC/MS or GC/MS has a very high sensitivity and is very accurate. The sample may consist of urine, saliva, blood, or hair, each with its own longevity of detection of drugs. For instance, a urine drug sample collected first thing in the morning concentrates the drugs and makes them easier to detect. For instance, an opioid in the blood may be undetectable in 6 hours whereas in saliva it is 21 hours, urine 4 days, and hair 1 year. Marijuana is undetectable in 6 hours after use in blood, 12 hours in saliva, 30 days (usually) in urine, and a year in hair. But the appearance of the drugs also vary depending on the specimen. For instance, opioids appear within 10 minutes in the blood, 1 hour in saliva, 2-5 hours in urine, and 5-7 days in hair. Length of Time Drugs of Abuse Can Be Detected in Urine: Alcohol 7-12 h, Amphetamine 48 h, Methamphetamine 48 h, Barbiturate Short-acting (eg, pentobarbital) 24 h, Long-acting (eg, phenobarbital) 3 wk, Benzodiazepine Short-acting (eg, lorazepam) 3 d, Long-acting (eg, diazepam) 30 d, Cocaine metabolites 2-4 d, Marijuana Single use 3 d, Moderate use (4 times/wk) 5-7 d, Daily use d Long-term heavy smoker >30 d, Codeine 48 h, Heroin (morphine) 48 h, Hydromorphone 2-4 d, Methadone 3 d, Morphine h, Oxycodone 2-4 d, Phencyclidine 8 d

4 Immunoassay techniques are most accurate for urine since the specimen is concentrated. For blood and saliva, usually GC/MS or LC/MS are used but occasionally immunoassays are performed as a screening test for saliva. Each immunoassay test technique has a cutoff value that is set high enough to avoid most false positives. For instance poppy seeds are known to contain small amounts of morphine. Therefore the DHHS (Department of Health and Human Services) has set the cutoff values for work related testing very high. Opioids are set at 2000ng/ml to be positive. This means the test is relatively insensitive for opioids, opioid pain killers, heroin, etc. that may show up as negative even if you are taking the medication several times a day. These is the same for the Department of Transportation in order to maintain or obtain the CDLs for driving. Immuno-testing cups in doctors offices may use more specific testing for different drugs. For instance, doctors frequently test for oxycodone and methadone and sometimes buprenorphine instead of simply testing for Opioids. These three medications are usually not picked up on federal testing cups and are rarely positive. The testing cups are with built in or separate testing (dip stick) strips, the number of strips chosen by the practice. Each strip usually shows one drug.

5 FALSE POSITIVE TESTING IMMUNOASSAY TECHNQUES While this varies from one manufacturer to another and the percentage of false positives vary, the following may trigger false positive urine drug screens: Cannabinoids (Marijuana): dronabinol (Marinol), efavirenz (Sustiva), ketoprofen (NSAID), naproxen (Aleve), pantoprazole (Protonix), ibuprofen (Advil), promethazine (Phenergan), riboflavin, tolmetin (NSAID), Niflumic acid (NSAID), some bath soaps Opioids: diphenhydramine (Benadryl), poppy seeds (Poppy seed dressing, hamburger buns), chlorpromazine (Thorazine), rifampin, dextromethorphan (found in several cough syrups), quinine (tonic water, antimalarial drug), ofloxacin (Floxin), papaverine (Pavabid) Amphetamines: DMAA (energy supplement), benzphetamine (Didrex), chlorpromazine (Thorazine), clobenzorex (Asenlix, Greenies ), isometheptene (Amidrine), isoxsuprine (Vasodilan), phentermine (Adipex), phenylpropanolamine (Dexatrim), promethazine (Phenergan), ritodrine (Yutopar), thioridazine (Mellaril), trazodone (Desyrel), trimethobenzamide (Tigan), trimipramine (Surmontil), ephedrine, methylphenidate (Ritalin, Concerta), pseudoephedrine (Sudafed), desipramine (Norpramin), bupropion (Welbutrin), fenfluramine (Pondimin), propranolol (Inderal), labetalol (Normodyne), mexiletine (Mexitil), selegiline (Eldepryl), tyramine amantadine (Symmetrel), ranitidine (Zantac), phenylephrine (Sudafed PE), vapor sprays (Vick s) PCP: doxylamine (Unisom), ibuprofen, (Advil, Motrin), imipramine (Tofranil), ketamine (Ketolar), meperidine (Demerol), mesoridazine (Serentil), tramadol (Ultram), chlorpromazine (Thorazine), thioridazine (Mellaril), dextromethorphan (cough syrup), diphenhydramine (Benadryl), venlafaxine (Effexor), synthetic cathinones (Bath Salts) Benzodiazepines: flunitrazepam (Rohypnol),oxaprozin (Daypro), sertraline (Zoloft), some herbal agents including valerian, EFV (efavirenz) Ethanol: asthma inhalers, diabetics with lactic acidosis or with elevated blood sugars and the sample is not analyzed within 12 hours Tricyclic Antidepressants: quetiapine (Seroquel), cyclobenzaprine (Flexeril), carbamazepine (Tegretol) Buprenorphine: heroin, morphine, methadone, dihydrocodeine Methadone: quetiapine (Seroquel) LSD: sertraline (Zoloft), ambroxol, Amitriptyline, benzphetamine, bupropion, buspirone, cephradine, chlorpromazine, desipramine, diltiazem, doxepin, fentanyl, fluoxetine, haloperidol, imipramine, labetalol, metoclopramide, prochlorperazine, risperidone, sertraline, thioridazine, trazodone and verapamil, Ergonovine, lysergol, brompheniramine maleate, imipramine HCl and methylphenidate HCl

6 FALSE POSITIVES GC/MS or LC/MS Technically there are no false positives for these tests since they measure the actual molecule in the body, unless there is some gross error in laboratory equipment or calibration. Most drugs are metabolized to other drugs in the body that may then be detected on GC/MS or LC/MS. The metabolites are important clues as to the presence or absence of a drug in the body. For instance, if a person tries to adulterate the urine with a small amount of the drug that is to be taken (the patient forgot for the past 4 days to take the medication), then there will be no metabolite but only the parent drug. Benzodiazepines: Diazepam (Valium) is metabolized in the body to both temazepam (Restoril) and oxazepam (Serax). A patient being prescribed Valium will therefore show up with all three drugs in their system. This is not a false positive, but is a metabolic process that is normal. Many physicians are unaware of these pathways. Chlordiazepoxide (Librium) is metabolized into nordiazepam (a metabolite of Valium) and oxazepam (Serax). Temazepam (Restoril) is metabolized into oxazepam (Serax) Hydromorphone: Hydromorphone (Dilaudid) is metabolized into morphine in 2/3 of patients. Morphine is found in a ratio of no more than 2% of the concentration of hydromorphone. Codeine: Codeine is metabolized into morphine and a small amount of hydrocodone. Morphine and its metabolites are expected normal for those taking codeine as well as a small amount of hydrocodone. Hydrocodone: Hydrocodone is metabolized into hydromorphone via the CYP2D6 liver metabolic pathway. In urine drug testing, the concentration of hydromorphone may be greater than that of hydromorphone. Oxycodone: Oxycodone is metabolized in part to oxymorphone via the CYP2D6 liver pathway. Heroin: Heroin is very rapidly metabolized into morphine. Heroin itself is rarely seen in urine drug testing due to this rapid metabolism. Amphetamine/Methamphetamine: This drug may show up on confirmation testing even if the person is not taking methamphetamine or any amphetamine containing drug. A sophisticated urine drug testing unit can ferret out the probability of the person consuming an illegal drug, but not entirely. Street methamphetamine (crystal meth) is a mixture of the d and l isomer of methamphetamine but has more than 20% as the d-isomer

7 Desoxyn is the prescription form of pure d-methamphetamine Benzphetamine (Didrex) is a Schedule III drug used to treat obesity and has d-methamphetamine as a primary metabolite. Vicks vapor rub is metabolized primarily into the l-isomer of methamphetamine Selegiline (Eldepryl) is a Parkinson s disease treatment that is metabolized into the l-isomer of methamphetamine. Amphetamines are a metabolite of methamphetamine but is also a prescription drug (Adderall). THEREFORE: A person with methamphetamine in the UDS is using crystal meth, Didrex (prescription), Desoxyn (prescription), Selegiline (prescription) or Vicks vapor rub (over the counter). Further testing for the d-isomer would be positive for crystal meth, Didrex, Desoxyn, or Selegiline. Testing of the d:l ratio would show 100% for Desoxyn and less than this (but more than 20%) for methamphetaime, Didrex, or Selegiline. A patient having <20% d isomer is presumed positive for Vicks vapor rub. The patient would have a prescription for Didrex, Desoxyn, or Selegiline. FALSELY ELEVATED OR FALSELY LOW LEVELS OF DRUG Some confirmation reference labs will try to calculate how much drug a person should have in their system based on the specific gravity (concentration) of the urine. These have not been confirmed in chronic pain patients taking opioids and there are many things that can affect this value. Some doctors will accuse their patients not taking the medication as prescribed due to a value that is either too high or too low compared with the calculated values. However these calculated values do not take into account the known liver enzyme inducers and inhibitors that are known to elevate or suppress the level of the drug in the body. For instance drugs that are metabolized by the CYP2D6 pathway (codeine, hydrocodone, hydromorphone) may have elevated values if the patient is also taking chlorpheniramine (found in cough and cold medicines and allergy medicines), cimetidine (Tagamet), ranitidine (Zantac), celexicob (Celebrex), amiodarone, chlorpromazine, haloperidol, duloxetine, citalopram, escitalopram, fluoxetine, paroxetine, sertraline, clomipramine, bupropion, moclobemide, doxorubicin, ritonavir, terbinafine. Additionally, 1-7% of Caucasians

8 lack the gene to use the CYP2D6 pathway, therefore codeine and hydrocodone measured values in urine drug tests may be elevated in these patients. Ironically, those with this genetic defect derive very little benefit from codeine or hydrocodone since they function as prodrugs that are metabolized into the more active morphine and hydromorphone respectively. On the other hand, drugs metabolized by this pathway may have falsely low values if the patient is also taking the antibiotic rifampin or the steroid dexamethasone (oral or injected) Other medications such as tramadol are affected by the 3CA pathway that may be inhibited by antidepressant drugs, especially the tricyclic antidepressants (e.g. Elavil, amitriptyline, Flexeril, cyclobenzaprine, nortriptyline, trimipramine, doxepin, desipramine, amoxapine, protriptyline). The levels of tramadol may become very high when taking these medications, to the point of causing seizures. There are also other metabolic pathways for morphine, hydromorphone, and oxymorphone that can be influenced by other medications, but the influence is not as clear as it is with the previously discussed medications. OTHER WAYS THE URINE DRUG SCREENS CAN BE INCORRECT 1. Incorrect labeling. In a busy medical practice, urine drug specimens may be collected and analyzed on-site using a drug analyzer. These medical practices use the least expensive cups possible, frequently without any labeling on them, and may collect them in a box connected to the restroom. If the cup has no label on it with an identifier, your specimen may be comingled with many other specimens in the same box. This system is fraught with potential inaccuracy, and may result in a specimen that is not your urine being attributed to you. ALWAYS CHECK THE URINE CUP FOR A LABEL WITH A UNIQUE IDENTIFYING NUMBER THAT IS LINKED TO YOUR NAME. Initials written on the cup are inadequate for documentation of identity and is a failure in the chain of custody of the sample. 2. Spillage of a specimen. If your sample is partially spilled in transit to a confirmatory lab, it is possible other specimens spilled, leading to mixing of the urine specimens. Not infrequently with some companies, the top is loosened or dislodged causing spillage, or the top of the container is improperly sealed.

9 3. Failure to divulge all medications being taken at the time of the specimen collection. This may result in a metabolite giving a positive result, and without your accurate medication list may cause issues with your prescribing physician 4. Placing opioid tablets or capsules in a bottle with other opioids no longer taken. Mixing the medications in the same bottle may lead to one medication rubbing off on another resulting in a drug screen positive for both medications. 5. Pill counts by physician s staff or pharmacies not using a clean counting surface. A surface that is not freshly clean may result in contamination of pills being counted on that surface. This is a very low likelihood occurrence. 6. Adulterants. Some patients will try to fool the drug test by adding adulterants such as bleach, but many immunoassay strips now have adulterant detection panels that show if the patient tried adding something to the urine to fool the urine drug test. 7. Incorrect report viewed by the doctor. If the physician s staff places the wrong report on a patient s chart, it may cause confusion and chaos for the patient. Ask to see the report if it has data that you know is incorrect. 8. Failure of the confirmation lab to wait long enough before all the drug from the last test was off the high pressure chromatography column. Failure to wait long enough will result in overlap of the samples, and a false positive result. This is very rare. OTHER SOURCE FALSE POSITIVES/NEGATIVES If the specimen was blood, there is only a very short window of time to collect and analyze the specimen. If saliva, the window is much less than for urine, and there may be not enough sample in the specimen to analyze. WHAT NOT TO DO 1. Failure (refusal) to take a urine drug test will automatically place a red flag in your file, and many physicians will not give any further controlled substances after this point, ever. If you can t give a specimen immediately, stay in the office and drink nonstop until you can.

10 2. Do not try to fool the test by bringing in powdered urine from the internet to mix on site. There are several ways to detect this behavior. 3. Do not try to claim your UDS is positive for THC (marijuana) because you were hanging around friends in a car. This has been shown to be non-sensical, and has been tested. 4. Do not expect to be given a second chance on a failed urine drug test that was confirmed with GC/MS or LC/MS. If the results are incorrect, use this guide to figure out why, then discuss it with your physician. REFERENCES: Saitman et. al J Anal Tox Sept 2014;38(7), Moeller Mayo Clin Proc Jan 2008: 83(1): rd Annual Meeting of the American Academy of Pain Medicine, February 2007: Abstract 152. DeGeorge, Jr. Practical Pain Management Nov 2012 Methamphetamine Urine Toxicology Pain Physician Journal: Opioid Special Issue July 2012;15:ES119-S133

Urine Drug Testing Methods 3-5

Urine Drug Testing Methods 3-5 Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry

More information

Physician s Reference for Urine and Blood Drug Testing and Interpretation

Physician s Reference for Urine and Blood Drug Testing and Interpretation Physician s Reference for Urine and Blood Drug Testing and Interpretation DETECTIMED PANEL Urine (test code 70195) Screen Confirmation Screen Confirmation Alcohol Ethanol Amphetamines Amphetamine Methamphetamine

More information

10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent?

10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent? Objectives Drug Testing Interpretation in Addiction Care Brandi Puet, Pharm.D. Describe the difference between immunoassay and confirmatory testing. List explanations for unexpected negative or positive

More information

Drug Screening. Separating Facts from Myths

Drug Screening. Separating Facts from Myths Drug Screening Separating Facts from Myths Today s Presenter: Todd Shoulberg, EVP ClearStar Medical Information Services Todd Shoulberg, Executive Vice President of Medical Information Services for ClearStar,

More information

Forensic Toxicology Scope of Testing and Detection Limits

Forensic Toxicology Scope of Testing and Detection Limits Forensic Toxicology Scope of Testing and Detection Limits Table of Contents QUALITATIVE ANALYSES... 2 Volatile Screen by GC/FID... 2 Carbon Monoxide by Microdiffusion... 2 Ethylene Glycol by GC/MS... 2

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J. Drug Adherence Assessment Report Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED PRESCRIPTION FLAG ANTICIPATED

More information

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Dr. Bhushan M. Kapur Associate Professor Department of Laboratory Medicine and Pathobiology, Faculty

More information

PROJECT ECHO OPIOID USE DISORDER IN PREGNANT WOMEN

PROJECT ECHO OPIOID USE DISORDER IN PREGNANT WOMEN PROJECT ECHO OPIOID USE DISORDER IN PREGNANT WOMEN 1 OPIOID USE DISORDER IN WOMEN Recognition & Prevention Date: August 14 th, Time: 8 am Presenters: Deepa Nagar MD, Andria Peterson PharmD Maternal Treatment

More information

Testing for Controlled Substances

Testing for Controlled Substances Testing for illicit drugs Testing for Controlled Substances 1 Purposes: Employment Sports Screening medical eval. Legal Monitoring Treatment Probation Prescribing controlled substances Forensics 2 Drug

More information

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) Email: DREtox@chematox.com; Phone: (303)440-4500 Always identify any medications/drugs the suspect states they have taken, or that you suspect

More information

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Controlled Substance Monitoring in the Age of the Opioid Epidemic Controlled Substance Monitoring in the Age of the Opioid Epidemic Paul E. Hilliard, MS, MD Hospital Pain Committee Chair Department of Anesthesiology CME housekeeping I have no financial disclosures AKA,

More information

Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing

Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing Mississippi Primary Health Care Association Pearl, MS March 7, 2018 Scott Hambleton, MD, DFASAM Medical

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY A report from the Office of Epidemiology and Planning Baltimore

More information

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain Faculty Disclosure Henry C. Nipper, PhD, DABCC Dr. Nipper has listed no financial interest/arrangement that would be considered a conflict of interest. Urine Drug Testing to Monitor Opioid Use In Managing

More information

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions September 2016 HCMC Toxicology Transition: Additional information and Frequently Asked Questions Many clinicians have asked for more information about the Urine Drug Compliance Analysis (LAB8742) switch

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY 2009 FINAL REPORT INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY This report was prepared by: Dr. Jose Arbelaez, M.D. of Baltimore Substance Abuse Systems, and Ryan J. Petteway,

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: HYDROMORPHONE (DILAUDID, EXALGO), CYCLOBENZAPRINE (FLEXERIL), METHADONE (METHADOSE),

More information

A Review of the Methods, Interpretation, and Limitations of the Urine Drug Screen

A Review of the Methods, Interpretation, and Limitations of the Urine Drug Screen Section Editor: Kelly M. Smith, PharmD, BCPS, FASHP, FCCP A Review of the Methods, Interpretation, and Limitations of the Urine Drug Screen E. Claire Markway, PharmD; Stephanie N. Baker, PharmD, BCPS Abstract:

More information

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date

More information

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital What Your Drug Test Really Means Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital Disclosure There are no relevant financial relationships with commercial interests associated.

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - MEDICATION DETECTED (PARENT DRUG

More information

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082 Alcohol The alcohol of interest is ethanol. Ethanol has a sedative effect in the brain. Ethanol intoxication symptoms include blurred vision, slurred speech, poor coordination and difficulty thinking depending

More information

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Frederick G. Strathmann, PhD, DABCC, (CC,TC) Medical Director, Toxicology Associate Scientific Director of MS ARUP Laboratories

More information

Urine Drug Testing (UDT) in Pain Management. Nov 27, 2017

Urine Drug Testing (UDT) in Pain Management. Nov 27, 2017 Urine Drug Testing (UDT) in Pain Management Nov 27, 2017 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or

More information

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) 1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory

More information

Laboratory Service Report

Laboratory Service Report 4 05/25/19 Client C702884-DLP ROCHESTER Amphetamines, Confirmation Positive Confirmed POSITIVE by LC-S/S for the following: Amphetamine = 52 ethamphetamine = 124 ethamphetamine exists in the d- and l-isomeric

More information

Urine Drug Screening: A Valuable Office Procedure

Urine Drug Screening: A Valuable Office Procedure Page 1 of 12 American Family Physician Return to Previous Page Mar 1, 2010 Table of Contents Urine Drug Screening: A Valuable Office Procedure JOHN B. STANDRIDGE, MD; STEPHEN M. ADAMS, MD; and ALEXANDER

More information

Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM

Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, 2018 12 1 PM Audio is available through your computer speakers. Mission Maine Quality Counts is a nonprofit

More information

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva)

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva) CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva) Cat. No.: DTSJZ023 Pkg. Size: Intended Use The CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva) is an immunochromatography based one step

More information

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016 Urine Drug Testing Methadone/Buprenorphine 101 Workshop Ron Joe, MD, DABAM December 10, 2016 Learning objectives Clarify the purpose of urine drug testing (UDT) Distinguish between UDT for detection of

More information

Medications and Children Disorders

Medications and Children Disorders Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for

More information

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS Barry K Logan PhD, DABFT National Director of Forensic Services, NMS Labs Willow Grove PA Disclaimer

More information

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly Utilization of the urine drug screen: The good, the bad, and the ugly Jennifer A. Lowry, MD Chief, Section of Medical Toxicology Children s Mercy Hospital Kansas City, MO Learning Objectives Describe the

More information

Urine drug testing it s not always crystal clear

Urine drug testing it s not always crystal clear Urine drug testing it s not always crystal clear Kirk Moberg, MD, PhD, FASAM Executive Medical Director, UnityPoint Health Illinois Institute for Addiction Recovery Clinical Professor of Internal Medicine

More information

Drug Adherence Assessment Report

Drug Adherence Assessment Report Prescribed Medications: Drug Adherence Assessment Report FENTANYL, OXYCODONE CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED ANTICIPATED TEST PRESCRIPTION (S)

More information

1. Amphetamine (Adderall, desoxyn, Dexedrine,dextrostat, spancap, oxydess II)

1. Amphetamine (Adderall, desoxyn, Dexedrine,dextrostat, spancap, oxydess II) Cross reactivity of various pharmaceuticals against the Drugs of Abuse Screening Panel (posted 2/3/09) The following tables are only applicable to the specific analyzer and reagents used at HRHS main lab.

More information

Urine Drug Testing (UDT) to Monitor Opioid Use. Feb 2018

Urine Drug Testing (UDT) to Monitor Opioid Use. Feb 2018 Urine Drug Testing (UDT) to Monitor Opioid Use Feb 2018 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or

More information

Urine Drug Testing (UDT) in Pain Management. Nov 5, 2017

Urine Drug Testing (UDT) in Pain Management. Nov 5, 2017 Urine Drug Testing (UDT) in Pain Management Nov 5, 2017 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or

More information

You Can t Fool the Bladder Police. Effective Use of Urine Drug Screening

You Can t Fool the Bladder Police. Effective Use of Urine Drug Screening You Can t Fool the Bladder Police Effective Use of Urine Drug Screening Why Test? Accountability Create and maintain safe treatment environment Compliance with licensing or policy Collection Supervised

More information

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing EDUCATIONAL COMMENTARY 2003 3 rd TEST EVENT Chemistry Urine Drug Testing Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE

More information

nextgen precision Test Report

nextgen precision Test Report nextgen precision TM Test Report SUMMARY OF PRECISION S NEXTGEN TEST REPORT In an effort to provide as much clinical insight as possible to our providers, we created our comprehensive NextGen Precision

More information

3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management

3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management Urine Drug Testing in Chronic Pain Management March 8, 2018 Faculty/Presenter Disclosure Faculty: Andrew J Smith, MDCM Relationships with commercial interests: None to report Andrew J Smith, MDCM Staff

More information

The Drug Testing Process. Employer or Practice

The Drug Testing Process. Employer or Practice Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine

More information

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching Liquid Chromatography Mass Spectrometry SSI-LCMS-8 LCMS-8 Drugs of Abuse: Analytes with Polarity Switching LCMS-8 Summary Seventy six analytes and their internal standards are described below. Multiple

More information

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Pain Management and Compliance Toxicology Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Prescription Drug Abuse: A National Problem Prescription drug abuse is a growing

More information

ToxCup Drug Screen Cup Step-by Step Instructions

ToxCup Drug Screen Cup Step-by Step Instructions ToxCup Drug Screen Cup Step-by Step Instructions This is a preliminary screening test that detects drug-of-abuse in urine at specified detection levels. To confirm preliminary positive results, a more

More information

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies Procedure: Status DS Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature Distributed to # of Copies Distributed to # of Copies PRINCIPLE: The Status DS 10 Panel (MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP)

More information

Pre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None

Pre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None Pre - PA Allowance None Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist and/or the member has paid pharmacy claims for an oncology medication(s) in the past

More information

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017 Welcome! Supreme Court of Ohio Specialized Dockets Conference October 23-24, 2017 Drug Testing: Do you know enough to be dangerous? Presented by William L. Parker President & CEO American Court & Drug

More information

Urine Opioid Dependency Panel (UODP) 1

Urine Opioid Dependency Panel (UODP) 1 Drug Testing Panels Urine Opioid Dependency Panel (UODP) 1 Amphetamines Amphetamine Methamphetamine Methylenedioxyamphetamine Adderall, Dexedrine, Vyvanse, Lisdexamfetamine (Speed, Bennies, Crystal Meth,

More information

2015 Annual Physician Notice

2015 Annual Physician Notice 0 Annual Physician Notice The Office of Inspector General (OIG) recommends clinical laboratories send notices to physicians and other providers who use their services, at least once a year, to inform the

More information

Appendix: Psychotropic Medication Reference Tables

Appendix: Psychotropic Medication Reference Tables Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic

More information

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance

More information

DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc.

DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc. Accuracy The accuracy of the DrugSmart Drugs of Abuse Tests was evaluated in comparison to commercially available drug screen tests. Sixty (60) negative urine samples collected from presumed non-user volunteers

More information

Drug Testing Basics. by Erowid

Drug Testing Basics. by Erowid Drug Testing Basics by Erowid INDEX 1. What do they Test for? 2. Test Types 3. Test Sensitivity 4. Detection Periods WHAT DO THEY TEST FOR? The first thing to know about drug testing is what the standard

More information

Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids

Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids PO-CON1753E Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids ASMS 2017 TP-442 Joshua F. Emory 1, Nathan DeFreitas 2, Michael Roberts 1, Manoj Tyagi 2, M.

More information

POINT OF CARE TESTING

POINT OF CARE TESTING POINT OF CARE TESTING POINT OF CARE INSTANT TESTING Randox Testing Services offers a wide range of products to enable you to carry out on-site drug and alcohol testing for instant results. Our products

More information

HYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist.

HYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist. Pre - PA Allowance None Prior authorization is not required if prescribed by an oncologist. Prior-Approval Requirements Age 18 years of age or older Diagnosis Patient must have the following: 1. Pain,

More information

Cross-reactivity reactivity in EMIT

Cross-reactivity reactivity in EMIT Blood Drug Analysis at the State Bureau of Investigation Crime Laboratory Richard W. Waggoner, Jr. Sample Requirements 2-10 ml gray top vacutainers At least 10 ml of urine sample for drug facilitated sexual

More information

MORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone)

MORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone) Pre - PA Allowance Tablets & Suppositories Morphine sulfate tablets Morphine sulfate suppositories Oxymorphone tablets Hydromorphone tablets Hydromorphone suppositories 360 tablets per 90 days OR 360 suppositories

More information

Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.

Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory. Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory Lyndsey.Knoy@wsp.wa.gov Forensic Toxicology is an interdisciplinary science that analyzes blood, fluid and/or tissues for

More information

Does ultram show up as an opiate

Does ultram show up as an opiate Search Does ultram show up as an opiate Tramadol ( Ultram ) is prescribed for treating moderate to severe pain in adults. 19-2-2018 I took Tramadol Hydrochloride for 6 months due to joint pain from my

More information

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography Application Note LCMS-109 A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography Time of Flight (LC-TOF) Mass Spectrometry Introduction Many clinical

More information

Have You Ever Wondered

Have You Ever Wondered Have You Ever Wondered A few facts about medication use and related falls The Number of Medications You Take & The Connection to Falls CONCERN: As you increase the number of medications that you take,

More information

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA *We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening

More information

Pain Medication Management Program Supports Patient Outcomes and Adherence

Pain Medication Management Program Supports Patient Outcomes and Adherence PeaceHealth Laboratories UPDATE 2015 Revised Edition Pain Medication Management Program Supports Patient Outcomes and Adherence BENEFITS Monitors analgesic medication adherence to ensure patient safety

More information

Drugs Found in Medical Examiner Cases

Drugs Found in Medical Examiner Cases s Found in Medical Examiner Cases 1,1 difluoroethane propellant in aerosols 10-Hydroxycarbazepine 11-Hydroxy Delta-9 THC 6-monoacetylmorphine 7-amino clonazepam acetaminophen acetone alpha-hydroxyalprazolam

More information

Pain Medication Management Program Monitors Patient Compliance

Pain Medication Management Program Monitors Patient Compliance PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your

More information

Can adderall cause a false positive on a drug test

Can adderall cause a false positive on a drug test Can adderall cause a false positive on a drug test The Borg System is 100 % Can adderall cause a false positive on a drug test If you're about to take a drug test, watch out if you are taking one of these

More information

Urine Drug Screening: The Essentials of Interpretation

Urine Drug Screening: The Essentials of Interpretation Urine Drug Screening: The Essentials of Interpretation Loralie J Langman, PhD DABCC (CC, MD, TC), F-ABFT Director Clinical and Forensic Toxicology Laboratory, Mayo Clinic Professor, Mayo Clinic College

More information

Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva. Edward J. Cone, Ph.D.

Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva. Edward J. Cone, Ph.D. Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva Edward J. Cone, Ph.D. Johns Hopkins School of Medicine, Baltimore, MD & ConeChem Research,

More information

Flexeril positive for benzos

Flexeril positive for benzos Flexeril positive for benzos Search 29-5-2014 Question - Does flexeril show up in drugtests tests,freedom again.i know flexeril is not a benzodiazepine that gave me the positive result for Benzos. include

More information

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get

More information

May Revised Urine Drug Screen Test Menu Effective mid-june Lauren Anthony, MD, MT(ASCP) SBB Medical Director, Allina Health Laboratory

May Revised Urine Drug Screen Test Menu Effective mid-june Lauren Anthony, MD, MT(ASCP) SBB Medical Director, Allina Health Laboratory May 2014 Lauren Anthony, MD, MT(ASCP) SBB Medical Director, Allina Health Laboratory Revised Urine Drug Test Menu Effective mid-june 2014 To better address the complexities of drug screening for different

More information

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine Reporting Title: Pain Clinic Drug Screen, CoC, U Performing Location: Rochester Specimen Requirements: Container/Tube: Chain-of-Custody Kit (Supply T282) containing the specimen containers, seals, and

More information

Patient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM

Patient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM Patient-Centered Urine Drug Testing Douglas Gourlay, MD, MSc, FRCPC, FASAM Declaration of Potential Conflict of Interest The content of this presentation is non- commercial and does not represent any conflict

More information

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Logan FSF Emerging Forensic Scientist Award Oral Presentation Disclosure

More information

Toxicology 101. Arizona Problem Solving Courts April 25, 2016

Toxicology 101. Arizona Problem Solving Courts April 25, 2016 Toxicology 101 Arizona Problem Solving Courts April 25, 2016 Aaron Brown, Ph.D. Technical Group Lead Norchem Drug Testing Laboratory Cordant Health Solutions Flagstaff, Arizona Toxicology Toxicology is

More information

DrugConfirm Advanced Urine Dip Cards.

DrugConfirm Advanced Urine Dip Cards. DrugConfirm Advanced Urine Dip Cards The information in this presentation is a general overview on using the Confirm BioSciences DrugConfirm Advanced drug test cup but can be applied to many similarly

More information

Overview. Opioids and HIV Infection: From Pain Management to Addiction Treatment

Overview. Opioids and HIV Infection: From Pain Management to Addiction Treatment FORMATTED: 01/23/2017 New York, New York: February 24, 2017 Opioids and HIV Infection: From Pain Management to Addiction Treatment Chinazo Cunningham, MD, MS Professor of Medicine Albert Einstein College

More information

Cutoff levels for hydrocodone in a blood test

Cutoff levels for hydrocodone in a blood test Cutoff levels for hydrocodone in a blood test The premier DNA and drug testing company in the North Texas area. Specializing in legal cases but also provide testing for employers and private individuals.

More information

Clinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: PA.CP.MP.50

Clinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: PA.CP.MP.50 Clinical Policy: Reference Number: PA.CP.MP.50 Effective Date: 01/18 Last Review Date: 09/17 Coding Implications Revision Log Description Urine drug testing is a key diagnostic and therapeutic tool that

More information

Drug Testing: How to Evaluate Results

Drug Testing: How to Evaluate Results Drug Testing: How to Evaluate Results Prepared for you by the West Virginia Drug Testing Laboratory Drug testing, whether for an individual or a large corporation, consists of two necessary steps - specimen

More information

The Utility of Urine Drug Screening

The Utility of Urine Drug Screening The Utility of Urine Drug Screening Treating Addiction, Saving Lives Sea Cruises Bye Tazmania, still far from New Zealand February 8 th, 2018 Mandy Manak, MD FASAM, ISAM, CSAM, MRO Medical Director, ICDO

More information

DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide.

DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide. DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide The information in this presentation is a general overview on using Confirm BioSciences DrugConfirm Advanced urine drug test cup; however,

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 11/13/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

Test Definition: PCDSO Pain Clinic Drug Screen, Urine Reporting Title: Pain Clinic Drug Screen, U Performing Location: Rochester Specimen Requirements: Collection Container/Tube: Plastic urine container Submission Container/Tube: Plastic, 60-mL urine bottle

More information

Levorphanol. Levorphanol Tartrate. Description

Levorphanol. Levorphanol Tartrate. Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.59 Subject: Levorphanol Page: 1 of 8 Last Review Date: March 16, 2018 Levorphanol Description Levorphanol

More information

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,

More information

DRUGS OF ABUSE TEST CUPS 14-DRUG PANEL WITH ADULTERANTS Step by Step Instructions

DRUGS OF ABUSE TEST CUPS 14-DRUG PANEL WITH ADULTERANTS Step by Step Instructions DRUGS OF ABUSE TEST CUPS 14-DRUG PANEL WITH ADULTERANTS Step by Step Instructions For in vitro diagnostic use The McKesson Consult Drugs of Abuse Test Cup is a screening test for the rapid qualitative

More information

Rapid Drug Test Cup Step-by Step Instructions

Rapid Drug Test Cup Step-by Step Instructions Rapid Drug Test Cup The CLIAwaived Inc. Rapid Drug Test Cup is an in vitro screening test for the rapid detection of multiple drugs in human urine at or above the following cutoff concentration: THC 11-nor-Δ9-Tetrahydrocannabinol-9-carboxylic

More information

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the

More information

Dynacare Laboratories

Dynacare Laboratories Dynacare Laboratories Affiliated with Froedtert & the Medical College of Wisconsin January 2015 2015 CPT Code Updates Dear Client: The American Medical Association (AMA) publishes the Current Procedural

More information

Hysingla ER. Hysingla ER (hydrocodone bitartrate) Description

Hysingla ER. Hysingla ER (hydrocodone bitartrate) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.38 Subject: Hysingla ER Page: 1 of 9 Last Review Date: September 15, 2017 Hysingla ER Description

More information

Many companies conduct drug screenings. But you better avoid the following nine items and save yourself a world of frustration, if you need

Many companies conduct drug screenings. But you better avoid the following nine items and save yourself a world of frustration, if you need 18-8-2017 Many companies conduct drug screenings. But you better avoid the following nine items and save yourself a world of frustration, if you need to pass the test 2-2-2018 25 Answers (question resolved)

More information

URINE DRUG TOXICOLOGY

URINE DRUG TOXICOLOGY Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences URINE DRUG TOXICOLOGY Suzanne E. Rapp, MD GENERAL DISCLOSURES The University of Washington School of Medicine also

More information

Intercept i2he Methamphetamine Oral Fluid Assay

Intercept i2he Methamphetamine Oral Fluid Assay Intercept i2he Methamphetamine FOR FORENSIC USE ONLY For Use with Intercept i2he Oral Fluid Collection Device 1001-0386 (65 ml Kit) INTENDED USE The Intercept i2he Methamphetamine is intended for use in

More information

Detection of Drugs-of-Abuse by Tandem Mass Spectrometry.

Detection of Drugs-of-Abuse by Tandem Mass Spectrometry. Detection of Drugs-of-Abuse by Tandem Mass Spectrometry. Dr Tim Laurens MSc.Chem(Pretoria), Ph.D. Chem (Pretoria), MSc.Toxicology (Surrey,UK) FRSChem, MFSSoc Email: laurensj@lancet.co.za / tim.laurens@up.ac.za

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 04/10/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

Drug Screening: Things You Need to Know

Drug Screening: Things You Need to Know Drug Screening: Things You Need to Know (a view inside the clinical laboratory) Gary L. Horowitz, MD Director, Clinical Chemistry, Beth Israel Deaconess Medical Center Associate Professor of Pathology,

More information